Pharmacogenomics and Personalized Medicine (PPM)

Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of human genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability. Pharmacogenomics and Personalized Medicine aims to serve both the academic and industrial communities and accepts research on the following topics: Genomic and proteomic profiling Genetics and drug metabolism Genetic variability in drug toxicity and efficacy Genetic-based vaccine development Targeted drug identification, discovery and delivery Optimizing drug selection and dosage based on patient's genetic profile Drug related morbidity and mortality intervention Advanced disease screening and targeted therapeutic intervention Practical and organizational challenges in the development and implementation of personalized medicine programs Patient satisfaction and preference Health economic evaluations of personalized medicine

Pharmacogenomics and Personalized Medicine (PPM) is :-

• International, Peer-Reviewed, Open Access, Refereed, Genomic and proteomic profiling, Genetics and drug metabolism, Targeted drug identification, Drug related morbidity, Patient satisfaction and preference, mortality intervention, Health economic evaluations , Online , Continuously Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 1178-7066, Established: 2008, Impact Factor: 1.8
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE